These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35387299)

  • 1. CDMOs Play a Critical Role in the Biopharmaceutical Ecosystem.
    Kurata H; Ishino T; Ohshima Y; Yohda M
    Front Bioeng Biotechnol; 2022; 10():841420. PubMed ID: 35387299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Launching a CDMO in Brazil aiming to develop biopharmaceuticals for clinical trials.
    Ferreira RS; Morales MM; Barretti P; Barraviera B
    J Venom Anim Toxins Incl Trop Dis; 2022; 28():e20220017. PubMed ID: 35721790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?
    Hole G; Hole AS; McFalone-Shaw I
    Int J Pharm X; 2021 Dec; 3():100095. PubMed ID: 34712948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contract development and manufacturing organization selection: critical considerations that can make or break your cell and gene therapy development.
    Pasdar MA; Sivilotti MM; Jaehn PS; Baghbaderani BA; Lee J; Levine BL; Milligan WD
    Cytotherapy; 2024 Jul; 26(7):656-659. PubMed ID: 38530691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape.
    Moorkens E; Meuwissen N; Huys I; Declerck P; Vulto AG; Simoens S
    Front Pharmacol; 2017; 8():314. PubMed ID: 28642701
    [No Abstract]   [Full Text] [Related]  

  • 6. Financial aspects and the future of the pharmaceutical industry in the United States of america.
    Karamehic J; Ridic O; Ridic G; Jukic T; Coric J; Subasic D; Panjeta M; Saban A; Zunic L; Masic I
    Mater Sociomed; 2013 Dec; 25(4):286-90. PubMed ID: 24511277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
    Szkodny AC; Lee KH
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2D and 3D inkjet printing of biopharmaceuticals - A review of trends and future perspectives in research and manufacturing.
    Evans SE; Harrington T; Rodriguez Rivero MC; Rognin E; Tuladhar T; Daly R
    Int J Pharm; 2021 Apr; 599():120443. PubMed ID: 33675921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving adoption of new technologies in biopharmaceutical manufacturing.
    Schaefer G; Balchunas J; Charlebois T; Erickson J; Hart R; Kedia SB; Lee KH
    Biotechnol Bioeng; 2023 Sep; 120(9):2765-2770. PubMed ID: 37053004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial technologies for biotherapeutics production: Key tools for advanced biopharmaceutical process development and control.
    Zalai D; Kopp J; Kozma B; Küchler M; Herwig C; Kager J
    Drug Discov Today Technol; 2020 Dec; 38():9-24. PubMed ID: 34895644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal on How To Conduct a Biopharmaceutical Process Failure Mode and Effect Analysis (FMEA) as a Risk Assessment Tool.
    Zimmermann HF; Hentschel N
    PDA J Pharm Sci Technol; 2011; 65(5):506-12. PubMed ID: 22293839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of China's Vaccine Incidents on the Operational Efficiency of Biopharmaceutical Companies.
    Chai KC; Tao R; Chang KC; Yang Y
    Front Public Health; 2020; 8():93. PubMed ID: 32322567
    [No Abstract]   [Full Text] [Related]  

  • 14. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.
    Buckley K; Ryder AG
    Appl Spectrosc; 2017 Jun; 71(6):1085-1116. PubMed ID: 28534676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS.
    Angeli F
    Health Policy Plan; 2014 May; 29(3):280-91. PubMed ID: 23558959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives.
    Singh N; Arunkumar A; Chollangi S; Tan ZG; Borys M; Li ZJ
    Biotechnol Bioeng; 2016 Apr; 113(4):698-716. PubMed ID: 26302443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop.
    Uppal A; Koduri CK; Yadlapalli S; Chirmule N; Chakrabarti R; Atouf F
    J Pharm Sci; 2020 Oct; 109(10):2958-2961. PubMed ID: 32710904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equipment and Analytical Companies Meeting Continuous Challenges May 20-21 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-831. PubMed ID: 28756844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-Return Analysis of the Biopharmaceutical Industry as Compared to Other Industries.
    Popa C; Holvoet K; Van Montfort T; Groeneveld F; Simoens S
    Front Pharmacol; 2018; 9():1108. PubMed ID: 30327601
    [No Abstract]   [Full Text] [Related]  

  • 20. Biopharmaceuticals from microorganisms: from production to purification.
    Jozala AF; Geraldes DC; Tundisi LL; Feitosa VA; Breyer CA; Cardoso SL; Mazzola PG; Oliveira-Nascimento L; Rangel-Yagui CO; Magalhães PO; Oliveira MA; Pessoa A
    Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):51-63. PubMed ID: 27838289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.